Stanley Michael D 4
4 · MEDNAX, INC. · Filed Feb 28, 2012
Insider Transaction Report
Form 4
Stanley Michael D
President, Pediatrix Division
Transactions
- Exercise/Conversion
Common Stock
2012-02-24$55.43/sh+9,800$543,214→ 30,525 total - Sale
Common Stock
2012-02-24$75.45/sh−9,800$739,435→ 20,725 total - Exercise/Conversion
Common Stock
2012-02-27$55.43/sh+4,053$224,658→ 24,778 total - Sale
Common Stock
2012-02-27$75.50/sh−4,053$306,000→ 20,725 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-02-24$55.43/sh−9,800$543,214→ 4,053 totalExercise: $55.43From: 2011-06-01Exp: 2018-06-02→ Common Stock (9,800 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2012-02-27$55.43/sh−4,053$224,658→ 0 totalExercise: $55.43From: 2011-06-01Exp: 2018-06-02→ Common Stock (4,053 underlying)
Footnotes (3)
- [F1]Sales of shares were made pursuant to Reporting Person's 10b5-1 trading plan.
- [F2]Sales of shares were executed in eighteen (18) separate transactions with prices ranging from $75.43 to $75.59 for a weighted average sales price of $75.4526.
- [F3]Sales of shares were executed in eighteen (18) separate transactions with prices ranging from $75.43 to $75.63 for a weighted average sales price of $75.4997.